Sen. Thomas R. Carper sold Viatris (VTRS)
Sen. Thomas R. Carper (D-DE) · $1K–$15K · traded Dec 30, 2020
- Transaction
- Sold (full)
- Amount
- $1K–$15K
- Owner
- Spouse
- Traded
- Dec 30, 2020
- Disclosed
- Jan 7, 2021
- Days to disclose
- 8
- Asset type
- Stock
- As filed
- Viatris Inc.
- Industry
- Drug Manufacturers - Specialty & Generic · Healthcare
Other trades in this filing
- Jan 7, 2021$1K–$15K
Sold (partial) DuPont de Nemours DD
$1K–$15K · Traded Dec 30, 2020 · disclosed Jan 7, 2021 · Spouse
- Jan 7, 2021$1K–$15K
$1K–$15K · Traded Dec 30, 2020 · disclosed Jan 7, 2021 · Spouse
- Jan 7, 2021$1K–$15K
$1K–$15K · Traded Dec 30, 2020 · disclosed Jan 7, 2021 · Spouse
- Jan 7, 2021$1K–$15K
Bought ALPS Medical Breakthroughs ETF SBIO
$1K–$15K · Traded Dec 30, 2020 · disclosed Jan 7, 2021 · Spouse
- Jan 7, 2021$1K–$15K
Bought Bristol-Myers Squibb Company BMY
$1K–$15K · Traded Dec 30, 2020 · disclosed Jan 7, 2021 · Spouse
- Jan 7, 2021$1K–$15K
Sold (full) Pembina Pipeline PBA
$1K–$15K · Traded Dec 30, 2020 · disclosed Jan 7, 2021 · Spouse
- Jan 7, 2021$1K–$15K
$1K–$15K · Traded Dec 30, 2020 · disclosed Jan 7, 2021 · Spouse
- Jan 7, 2021$1K–$15K
Bought Goldman Sachs Small/Mid Cap Growth Fund Institutio GSMYX
$1K–$15K · Traded Dec 15, 2020 · disclosed Jan 7, 2021 · Spouse
Recent Congress trades in VTRS
- Dec 15, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Nov 18, 2025 · disclosed Dec 15, 2025
- May 8, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded Apr 8, 2025 · disclosed May 8, 2025
- Apr 7, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
$1K–$15K · Traded Mar 31, 2025 · disclosed Apr 7, 2025
- Mar 28, 2025$1K–$15K
Rep. Robert P. Bresnahan, Jr. (R-PA-8)
$1K–$15K · Traded Feb 25, 2025 · disclosed Mar 28, 2025
- Dec 6, 2024$1K–$15K
- Feb 5, 2024$1K–$15K
- Jun 12, 2023$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded May 19, 2023 · disclosed Jun 12, 2023 · Spouse
- May 19, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
$1K–$15K · Traded Apr 10, 2023 · disclosed May 19, 2023
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.